Full Measure After Hours: Behind the Giant CPAP Machine Recall
Introduction
In the June 19, 2025 episode of Full Measure After Hours, host Sharyl Attkisson delves into the unprecedented safety recall of Philips Respironics' CPAP machines. This episode, titled "After Hours: Behind the Giant CPAP Machine Recall (From the Archives)," features investigative journalist Liz Mohan from ProPublica, who played a pivotal role in uncovering the depth of this major health concern.
Background of the CPAP Recall
Cheryl Akison opens the episode by setting the stage for one of the most significant medical device recalls in recent history. "In June of 2021, after discovering a potential health risk related to the foam used in some of these CPAP machines, Philips issued a voluntary recall," Akison explains (00:42). These Continuous Positive Airway Pressure (CPAP) machines are essential for millions suffering from sleep apnea, providing life-saving assistance by ensuring uninterrupted breathing during sleep.
Investigative Process
Liz Mohan elaborates on how ProPublica became involved in this investigation. "The topic of CPAPs came to me from the reporters who had already started this investigation," she states (02:13). Collaborating with the Pittsburgh Post Gazette, Mohan focused on the human impact behind the technical failures. She summarizes the story succinctly: "This is a story about patients and doctors who are impacted by the Philips Respironics recall of their CPAP machines... They withheld complaints from users who reported defects, and they withheld that information from the public" (03:01).
Human Impact: Patients and Doctors
The episode brings to light the personal toll of the recall through the story of the Stark family. Mohan describes them as a representation of the widespread fear among users: "They went on CPAP machines as soon as their doctor diagnosed them with sleep apnea... but all along they were doing the right things. And yet they're told your health might be harmed from using these machines" (05:51).
Additionally, the documentary highlights the chaos experienced by healthcare providers. Dr. Braden from Hillsboro, Oregon, recounts the tumultuous weeks following the recall, where "20,000 patients... were calling, asking for direction. But the doctors were caught in the middle too" (10:20). This unprecedented situation left both patients and medical professionals grappling with uncertainty and fear.
Company and Regulatory Response
Philips' response to the recall has been a point of contention. The company acknowledged receiving over 3,700 complaints over 11 years but only initiated an investigation nine years after the first report (05:04). Mohan points out the discrepancy in Philips' characterization of the complaints: "3700 complaints were over the span of 11 years. They were not all at once. And then they withheld them trickling in" (05:48).
Despite initial FDA and Philips agreements acknowledging potential risks—such as asthma and respiratory problems—Philips later downplayed these concerns. They claimed that the initial testing was based on a worst-case scenario and maintained the machines' safety. "We cannot say if people using these machines have gotten sick because of the machines," Mohan emphasizes (07:02).
Ongoing Concerns and Lessons Learned
The FDA has remained vigilant post-recall, especially concerning the newer DreamStation 2 CPAP machines. Recent reports indicate over 270 instances of thermal issues between August and November 2023, a significant increase from previous years. However, the FDA notes that these issues are not related to the foam used in the machines.
Mohan reflects on the broader implications of the recall: "Sleep isn't a luxury, it isn't optional. We all have a right to sleep... we don't know if the machine could harm you, but we're letting you make that decision" (08:36). The overarching lesson highlights the critical importance of transparency and timely communication in healthcare to safeguard patient well-being.
Conclusion and Further Resources
The episode concludes by directing listeners to ProPublica's documentary "With Every Breath" for an in-depth exploration of the CPAP recall. Cheryl Akison also provides updates on Philips' remediation efforts and the FDA's ongoing vigilance (11:55).
For those seeking more information, resources include:
- ProPublica Documentary: Search "With Every Breath" on ProPublica.org or through your preferred search engine.
- FDA Warnings: Detailed information on the FDA's stance and updates can be found at the official FDA website.
- Full Measure TV Program: Watch the full report on Full Measure via CherylAkison.com or FullMeasure.News.
Notable Quotes:
- "We don't know if the machine could harm you, but we're letting you make that decision." – Liz Mohan (08:36)
- "Sleep isn't a luxury, it isn't optional. We all have a right to sleep." – Dr. Carol Stark (09:19)
- "This was one of the most chaotic and disruptive recalls in medical history." – Liz Mohan (10:20)
Key Takeaways:
- The Philips CPAP recall affected millions, raising serious concerns about product safety and corporate responsibility.
- Delayed response to consumer complaints exacerbated the crisis, highlighting the need for better regulatory oversight.
- The human stories behind the recall underscore the profound impact on both patients and healthcare providers.
- Ongoing vigilance by regulatory bodies like the FDA remains crucial to prevent future health risks.
This comprehensive investigation by Liz Mohan and ProPublica sheds light on the complexities and repercussions of one of the most significant medical device recalls, emphasizing the importance of transparency, accountability, and the fundamental right to safe and effective healthcare solutions.
